Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MNPR

Monopar Therapeutics (MNPR)

Monopar Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MNPR
DateTimeSourceHeadlineSymbolCompany
08/02/202509:01Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MNPRMonopar Therapeutics Inc
28/01/202516:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MNPRMonopar Therapeutics Inc
28/01/202509:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MNPRMonopar Therapeutics Inc
24/01/202505:10PR Newswire (US)Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar TherapeuticsNASDAQ:MNPRMonopar Therapeutics Inc
16/01/202509:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MNPRMonopar Therapeutics Inc
03/01/202510:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
03/01/202510:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
24/12/202408:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
23/12/202422:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MNPRMonopar Therapeutics Inc
21/12/202401:00GlobeNewswire Inc.Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded WarrantsNASDAQ:MNPRMonopar Therapeutics Inc
19/12/202409:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MNPRMonopar Therapeutics Inc
18/12/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MNPRMonopar Therapeutics Inc
18/12/202409:01Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MNPRMonopar Therapeutics Inc
18/12/202408:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
07/12/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
06/12/202408:21GlobeNewswire Inc.Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-LuNASDAQ:MNPRMonopar Therapeutics Inc
04/12/202400:00GlobeNewswire Inc.Monopar to Present at the 36th Annual Piper Sandler Healthcare ConferenceNASDAQ:MNPRMonopar Therapeutics Inc
30/11/202409:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MNPRMonopar Therapeutics Inc
09/11/202400:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
09/11/202400:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNPRMonopar Therapeutics Inc
09/11/202400:00GlobeNewswire Inc.Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent DevelopmentsNASDAQ:MNPRMonopar Therapeutics Inc
31/10/202407:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
31/10/202404:42GlobeNewswire Inc.Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common StockNASDAQ:MNPRMonopar Therapeutics Inc
30/10/202407:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MNPRMonopar Therapeutics Inc
29/10/202412:15GlobeNewswire Inc.Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common StockNASDAQ:MNPRMonopar Therapeutics Inc
29/10/202407:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MNPRMonopar Therapeutics Inc
29/10/202407:00GlobeNewswire Inc.Monopar Therapeutics Inc. Announces Proposed Public Offering of Common StockNASDAQ:MNPRMonopar Therapeutics Inc
24/10/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
24/10/202422:00GlobeNewswire Inc.Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug CandidateNASDAQ:MNPRMonopar Therapeutics Inc
22/10/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MNPR